Consolidated figures · ₹ crore
| ₹ Cr | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 35 | 34 | 41 | 39 | 29 | 25 | 37 | 26 | 21 | 21 | 16 | 12 | |
| COGS | 18 | 18 | 22 | 14 | 17 | 11 | 20 | 11 | 10 | 9 | 8 | 47 |
| Gross profit | 17 | 16 | 20 | 25 | 12 | 13 | 17 | 14 | 12 | 11 | 8 | -35 |
| 18 | 22 | 18 | 53 | 16 | 14 | 16 | 16 | 12 | 12 | 19 | 104 | |
| -0 | -6 | 1 | -28 | -4 | -1 | 1 | -2 | -0 | -1 | -11 | -139 | |
| OPM % | -0.9% | -17.6% | 3.1% | -73.7% | -13.4% | -2.6% | 2.9% | -7.8% | -1.3% | -4.7% | -68.3% | — |
| Depreciation | 5 | 5 | 5 | 6 | 4 | 4 | 7 | 6 | 5 | 5 | 5 | 12 |
| Interest | 11 | 12 | 13 | -33 | 0 | 0 | 0 | 2 | 1 | 2 | 1 | 1 |
| 0 | 2 | 0 | 8 | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 6 | |
| Profit before tax | -16 | -20 | -17 | 7 | -8 | -5 | -6 | -5 | -5 | -7 | -17 | -146 |
| Tax | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax % | 0% | 0% | -3.3% | 20.9% | 0% | 0% | 0% | 2.2% | 0% | 0% | 0% | 0.1% |
| -16 | -20 | -16 | 5 | -8 | -5 | -6 | -5 | -5 | -7 | -17 | -146 | |
| PAT margin % | -44.1% | -60.3% | -38.7% | 13.6% | -27.9% | -20.8% | -16.4% | -20.1% | -25.7% | -35.4% | -103.5% | — |
| EPS (₹) | 1.9 | -2.5 | -1.2 | 0.6 | -1 | -0.6 | -0.7 | -0.7 | -0.7 | -0.9 | -0.9 | -17.7 |
| Results filing | — | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 |
| vs same quarter last year | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | -29.5% | -23.9% | -25.6% | +4.3% | -16.9% | -26.4% | -11.9% | -33.7% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 31 Mar 2024 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities |
|---|---|---|---|---|
| Pharma Business | 35.38 | -9.36 | — | 0 |
| Speciality Chemicals Business | 3.23 | -24.94 | — | 0 |
₹ crore by quarter
| -27.2% |
| -16.8% |
| -56.2% |
| -53.1% |
| PAT YoY % | — | — | — | — | — | — | — | -197.7% | — | — | — | — |